IL2 and neoplasm: Moreover, our finding that abrogating PGE2 signalling in T cells enhances clonal expansion across the entire differentiation spectrum of anticancer TILs indicates that physiological IL-2 concentrations within tumours are sufficient to drive protective anticancer immunity if IL-2 signalling in TILs is restored.